MedTrace Logo

Studying Routine Patient Care With BIOTRONIK Devices That Allow a More Natural Heart Stimulation

NCT07393009 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2026-05-15

No results posted yet for this study

Summary

The registry is designed to assess outcome, performance and residual safety aspects of BIOTRONIK products which are used in the context of CSP based on long-term data from an unselected, real-life clinical set-up.

Conditions

  • Cardiac Pacing
  • Cardiac Pacemaker
  • Implantable Cardioverter Defibrillator
  • Cardiac Resynchronization Therapy Devices
  • Bradycardia
  • Tachycardia
  • Heart Failure

Interventions

DEVICE

Implantation of the Solia CSP S pacing lead for LBBAP

Observation of clinical routine care for patients implanted with BIOTRONIK devices used for conduction system pacing (CSP)

Sponsors & Collaborators

  • Biotronik SE & Co. KG

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-29
Primary Completion
2033-02-01
Completion
2033-02-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07393009 on ClinicalTrials.gov